Listed group unveils Stryker deal, page-12

read qaut its there black and white
is it that hard


QUARTERLY UPDATE ENDED DECEMBER 31, 2019

PuriflOH Limited (PO3, PuriflOH or Company) (ASX: PO3; OTCQX: PUFLF) is pleased to provide an update on status
of its Free Radical Generator (“FRG”) technology.
During the quarter ended December 31, 2019 the company undertook an internal review of the potential market
acceptance of PO3’s array of FRG opportunities and concurrently evaluated the readiness of the product portfolio
for commercialization. Whilst work on recreational water and sterilization systems continue, the review resulted in
an increased focus on the development of air purification products. This sector has recently been highlighted within
Australia due to the air quality issues experienced on the eastern seaboard.
These activities are reflected in part in the increased quarterly expenditure shown in the Appendix 4C.
The air purification product developments are assisting in ongoing discussions with OEMs. The ability to show a
prototype, particulary at the beta stage, is critical to a complete representation of the FRG technology. The
company has been focused on this step.
As previously noted, the results of the TB trials in India were put on hold because of unforeseen protocol deviations.
The prospects for using the FRG technologies in a new hotel project in Melbourne remain. The Company awaits
confirmation of this project.
The Company’s shares are now quoted for trading in the United States on the OTCQX marketplace. The Company
is in the process of finalizing its Depository Trust Company (“DTC”) Application for securities settlement services
through the DTC system.
Disruptive technology is not always readily embraced in established markets thereby creating delays in acceptance